
Delighted to share our latest preprint on mouse TLR8 biology, the result of a close collaboration with Seija Lehnardt and colleagues. We revisit long-standing assumptions about mouse TLR8 function: biorxiv.org/content/10.1101/…

Prof Michael Gantier's lab @Hudson_Research studies the immunology of nucleic acids (such as mRNA therapeutics)

Delighted to share our latest preprint on mouse TLR8 biology, the result of a close collaboration with Seija Lehnardt and colleagues. We revisit long-standing assumptions about mouse TLR8 function: biorxiv.org/content/10.1101/…

Into nucleic acid immunity? 🌏 Join #NAIS2026 in Nara, Japan! 📅 Sept 16–18, 2026 🧬 Abstract deadline (extended): June 30 📝 Register by: July 31 Explore the latest in nucleic acid immunity & connect with global experts. 🔗 ifrec.osaka-u.ac.jp/nais26/i…

Ever wondered what happens to oligonucleotide therapeutics once they start to break down? In our new bioRxiv preprint, we provide a molecular dissection of how chemically modified 3‑base oligonucleotide fragments engage TLR7 and TLR8. Check it out! doi.org/10.64898/2026.04.29.…

Researchers led by Drs. Michael Gantier (@GantierLab), Toshiyuki Shimizu, and Ben Corry (@CorryLab) show that modified #RNA from our own cells naturally blocks TLR7 and TLR8, preventing harmful immune activation. 📖: go.nature.com/4azVWjp 🔊: bit.ly/40muGA2


Recognition of RNA fragments by TLR7 and TLR8 helps to initiate the innate immune response. This work redefines TLR7 and TLR8 sensing by introducing 2′-OMe guanosine as a natural immune checkpoint for their activation. @NatImmunol 🔗 go.nature.com/4azVWjp

How does your immune system tell pathogenic RNA from your own, even though they’re made of the same stuff? Our latest paper with @GantierLab shows some self RNA act as an off switch preventing autoimmunity in the absence of pathogens. 🧬🔬⭐ nature.com/articles/s41590-0…

I am delighted to share our characterisation of natural antagonism of TLR7/8 in Nature Immunology. We propose a model where 2’O-Methyl RNA fragments keep TLR7/8 in check, preventing autoimmunity. > nature.com/articles/s41590-0…

IsomiR stoichiometry changes as disease biomarkers. dlvr.it/TLDYyK #MTNA

Excited to share our latest work on how microRNA length variants can be leveraged as disease biomarkers. Congratulations to Alex McAllan for all her work on this! cell.com/molecular-therapy-f…

For all RNA scientists in the Melbourne area: Join us at the next RNA Victoria Minisymposium on 27th of March at the Hudson Institute of Medical Research - details about the speakers and free registration at rnavic.com/

Follow us on gantierlab.bsky.social

Please mark your calendars for the next RNAVIc symposium. It will be July 22nd at WEHI Davis Auditorium starting at 2pm. rnavic.com/

We are thrilled to announce the official launch of the #RNAte Platform at @Hudson_Research, delivering huge advances in the development of #mRNA-based therapies. 🥳💪🏽 Read more about this revolutionary platform: bit.ly/3SEEl23 @VicGovAu @VicGov_DJSIR

We recently welcomed Deputy Premier & Minister for Medical Research, The Hon @BenCarrollMP to Hudson Institute! 🙌 Minister Carroll went behind the scenes with some of our researchers, including our CEO & Director Prof Elizabeth Hartland, to learn more about our research.🔬

Thrilled to be joining longtime friends and colleagues @CiiiD_Hudson including those I could find on twitter @ProfHartland @FerreroMicro @Tate_Lab @GantierLab @pjhpauljh @Forster_Lab @PhilBardin